Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Fibroepithelial Lesions of the Breast: A Spectrum

Fibroepithelial Lesions of the Breast: A Spectrum PurposeFibroepithelial breast lesions are a spectrum of entities ranging from common and benign to uncommon and malignant. Here we review the frequency, demographics, imaging, pathology, and behavior of these different lesions, to make the diagnosis and management of fibroepithelial lesions somewhat less challenging.MethodCurrent literature on fibroepithelial lesions was reviewed. This information was combined with our experience at a single academic institution.FindingsAlthough evaluation with newer technologies such as MRI or immunohistochemistry markers such as Ki67 and VEGF can be used to sort the spectrum of fibroepithelial lesions, accurate diagnosis remains challenging given the histologic variability and heterogeneity. Continuing advances in imaging and pathology analysis should make accurate classification easier in the future.SummaryThe majority of fibroepithelial lesions are benign, fibroadenomas being the most common mass diagnosed in women. Phyllodes tumor needs to be considered in a rapidly growing mass. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Radiology Reports Springer Journals

Loading next page...
 
/lp/springer-journals/fibroepithelial-lesions-of-the-breast-a-spectrum-UDi3S0LE0K

References (41)

Publisher
Springer Journals
Copyright
Copyright © Springer Science+Business Media, LLC, part of Springer Nature 2020
eISSN
2167-4825
DOI
10.1007/s40134-020-00373-z
Publisher site
See Article on Publisher Site

Abstract

PurposeFibroepithelial breast lesions are a spectrum of entities ranging from common and benign to uncommon and malignant. Here we review the frequency, demographics, imaging, pathology, and behavior of these different lesions, to make the diagnosis and management of fibroepithelial lesions somewhat less challenging.MethodCurrent literature on fibroepithelial lesions was reviewed. This information was combined with our experience at a single academic institution.FindingsAlthough evaluation with newer technologies such as MRI or immunohistochemistry markers such as Ki67 and VEGF can be used to sort the spectrum of fibroepithelial lesions, accurate diagnosis remains challenging given the histologic variability and heterogeneity. Continuing advances in imaging and pathology analysis should make accurate classification easier in the future.SummaryThe majority of fibroepithelial lesions are benign, fibroadenomas being the most common mass diagnosed in women. Phyllodes tumor needs to be considered in a rapidly growing mass.

Journal

Current Radiology ReportsSpringer Journals

Published: Nov 13, 2020

There are no references for this article.